Search form

68639

Immune-Related Response Criteria: Description and Use in the Management of CTLA-4 Blocking Antibody-Treated Patients

A subscription to the 2012 ASCO Annual Meeting is required to view presentations in this session Subscription Information
Video
Education Session
Chair(s): 
Mario Sznol, MD;
Developmental Therapeutics Track 2012 ASCO Annual Meeting

Immunotherapy with the T-Cell Checkpoint Antibodies: Implications for the Practitioner

F. Stephen Hodi, MD
Speaker

» Listen (Right-click to download audio)
A subscription to the 2012 ASCO Annual Meeting is required to view presentations in this session Subscription Information
More by F. Stephen Hodi :
Abstracts
  1. CRS-207 vaccine plus chemotherapy as front-line treatment for subjects with malignant pleural mesothelioma (MPM).

    Meeting: 2013 ASCO Annual Meeting
    Abstract No: TPS7607
    First Author: R. Hassan
    Category: Lung Cancer - Non-small Cell Local-regional/Small Cell/Other Thoracic Cancers - Mesothelioma
  2. Amatuximab, a chimeric monoclonal antibody to mesothelin, in combination with pemetrexed and cisplatin in patients with unresectable pleural mesothelioma: Results of a multicenter phase II clinical trial.

    Meeting: 2012 ASCO Annual Meeting
    Abstract No: 7030
    First Author: Raffit Hassan
    Category: Lung Cancer - Non-small Cell Local-regional/Small Cell/Other Thoracic Cancers - Mesothelioma
  3. Antitumor activity of SS1P with pemetrexed and cisplatin for front-line treatment of pleural mesothelioma and utility of serum mesothelin as a marker of tumor response.

    Meeting: 2011 ASCO Annual Meeting
    Abstract No: 7026
    First Author: R. Hassan
    Category: Lung Cancer - Local-Regional and Adjuvant Therapy/Small Cell - Adjuvant Therapy
more
Virtual Meeting Presentations
  1. Discussion: Optimizing Care in Advanced Lung Cancer

    Meeting: 2010 ASCO Annual Meeting
    Session: Lung Cancer - Metastatic(Oral Abstract Session)
    Discussant: Raffit Hassan
  2. The present state of trials using immunoconjugates targeting solid tumors and new strategies emerging from the lab.

    Meeting: 2010 ASCO Annual Meeting
    Session: Immunoconjugates as Cancer Therapeutics(Education Session)
    Speaker: Raffit Hassan
more
Educational Book Manuscripts
  1. “Right Drug for the Right Patient”: Hurdles and the Path Forward in Colorectal Cancer

    Source: 2013 Educational Book
    Category: Gastrointestinal (Colorectal) Cancer
  2. A Multidisciplinary Approach in Muscle-Invasive Disease: Novel Chemotherapy Combinations and Targets in Chemoradiation

    Source: 2013 Educational Book
    Category: Genitourinary Cancer
  3. Aberrant Epigenetic Regulation: A Central Contributor to Lung Carcinogenesis and a New Therapeutic Target

    Source: 2013 Educational Book
    Category: Lung Cancer
more